Pharmaceutical Industry Loans

Industry overview

With improved technology bases, stronger infrastructure development and an eclectic range of manufactured products, the pharmaceutical industry in India has witnessed enormous progress. The country’s ability to produce cost-effective drugs combined with its top-notch manufacturing facilities has also ensured a rising demand for exports. Pharma companies today have manufacturing facilities that are compliant with Good Manufacturing Practices (GMP), for the production of several dosage forms, and India’s production list now includes bulk drugs from major therapeutic groups which demand complicated processes.

Current industry

Pharmaceutical is a non-cyclic industry that has grown steadily over the past few years. The sector is highly organised with a host of multinational and domestic companies increasing operations in India. With rising consumption levels and a strong demand from export markets, the Indian pharmaceuticals industry has shown consistently phenomenal growth in the past few years. India possesses the largest number of manufacturing facilities approved by the US FDA outside the USA and at present, tops the list in filing drug master files (DMF) with the US FDA. The industry is estimated at about US$ 10 billion, and is advancing at an annual rate of 9%. The domestic industry stands fourth in terms of volume and thirteenth in terms of value in world rankings.

Expected growth

With multiplying health issues that necessitate advanced treatments, medical equipment finance is a steadily rising demand. In addition to GMP and WHO, many Indian companies get plants approved by international regulatory agencies such as the MCA (UK), FDA (UK), MCC (South Africa) and TGA (Australia). The Indian pharmaceutical industry is expected to touch US$ 35.9 billion by 2016 and is estimated to grow to US$ 55 billion by 2020, driven by increased affordability and a jump in market access.

EFL contribution

At EFL, we understand both the pharmaceutical industry’s current status and its expected growth. In some parts of the country, SMEs badly need funds to upgrade their manufacturing plants, and direct capital not being easily available, many of them close down. EFL has emerged as a prominent disburser of medical and healthcare equipment finance in India. We offer flawless support through our well drafted services and customised policies, and an expert team to guide you towards realising your business goals.

Machines we finance

  • Tablet manufacturing machines
  • Capsule manufacturing machines
  • Granulation equipment like FBD, mass mixers, blenders, multi mills, etc.
  • Ointment/cream/syrup manufacturing plants
EFL serves as a source of medical & healthcare equipment finance in India whenever you are looking out for equipment procurement!